Prolonged fibrinolytic prophylactic treatment with nicotinic acid derivatives and MAO-inhibitors.
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology*; D009539:Nicotinic Acids / Q000494:pharmacology*; D011817:Rabbits; D013923:Thromboembolism / Q000517:prevention & control*
D000614:Aminocaproates; D008996:Monoamine Oxidase Inhibitors; D009539:Nicotinic Acids; D007611:Aprotinin; D009526:Nialamide